Goodwill and Intangible Assets

9 Months Ended

Dec. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

4.	Goodwill and Intangible Assets

Goodwill

There was no change in Goodwill in the three and nine months ended December 31, 2016.

Intangible assets, net consisted of the following:

	Weighted	Gross				Net
	Average	December 31,		Accumulated		December 31,
	Life (Yrs.)	2016		Amortization		2016
Indefinite Lived Assets:
Medicare License	N/A	$	704,000	$	-	$	704,000

Amortized Intangible Assets:
Acquired Technology	5		1,312,500		(196,875)		1,115,625
Non-Compete	4		117,000		(85,689)		31,311
Network Relationships	5		220,000		(106,332)		113,668
Trade Name	5		191,000		(87,867)		103,133
		$	2,544,500	$	(476,763)	$	2,067,737

	Weighted	Gross				Net
	Average	March 31,		Accumulated		March 31,
	Life (Yrs.)	2016		Amortization		2016
Indefinite Lived Assets:
Medicare License	N/A	$	704,000	$	-	$	704,000
Acquired Technology	5		1,312,500		-		1,312,500

Amortized Intangible Assets:
Exclusivity	4		-		-		-
Non-Compete	4		117,000		(58,737)		58,263
Payor Relationships	5		-		-		-
Network Relationships	5		220,000		(73,333)		146,667
Trade Name	5		191,000		(59,218)		131,782
		$	2,544,500	$	(191,288)	$	2,353,212

There were no additions to the intangible assets in the three and nine months ended December 31, 2016. The amortization expense for the three and nine months ended December 31, 2016 and 2015 was approximately $95,000 and $285,000, $47,000 and $141,000 respectively.

The following table summarizes the approximate expected future amortization expense as of December 31, 2016 for definite-lived intangible assets:

2017 (remaining 3 months)	$	95,000
2018		360,000
2019		349,000
2020		297,000
2021		264,000

	$	1,365,000

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details